Nektar Therapeutics GAAP EPS of -$0.32 beats by $0.13, revenue of $22.02M misses by $0.19M
Nektar Therapeutics GAAP EPS of -$0.32 beats by $0.13, revenue of $22.02M misses by $0.19M
SeekingAlpha
0 shares
1 views
You might like
Related news coverage
-
Crinetics Pharmaceuticals GAAP EPS of -$0.84 misses by $0.01, revenue of $0.71M beats by $0.41M
SeekingAlpha
-
Alkaline Water GAAP EPS of -$0.03 beats by $0.01, revenue of $15.9M misses by $2.76M
SeekingAlpha
-
Assured Guaranty Non-GAAP EPS of $0.22 misses by $0.76, revenue of $292M beats by $109.66M
SeekingAlpha
-
Rogers Non-GAAP EPS of $1.04 beats by $0.18, revenue of $23.7M misses by $211.7M
SeekingAlpha
Advertisement
More coverage
-
Green Thumb Industries Non-GAAP EPS of $0.05 misses by $0.01, revenue of $259.3M beats by $2.75M
SeekingAlpha
-
Fate Therapeutics GAAP EPS of -$0.58 beats by $0.29, revenue of $44.34M beats by $25.93M
SeekingAlpha
-
Coupang GAAP EPS of $0.06 beats by $0.02, revenue of $5.3B misses by $70M
SeekingAlpha
-
Cronos Group GAAP EPS of -$0.21 misses by $0.16, revenue of $22.89M beats by $0.71M
SeekingAlpha